Selective Inhibitors of Fatty Acid Amide Hydrolase Relative to Neuropathy Target Esterase and Acetylcholinesterase: Toxicological Implications
- 15 February 2002
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 179 (1) , 57-63
- https://doi.org/10.1006/taap.2001.9342
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolaseProceedings of the National Academy of Sciences, 2001
- Membrane Association of and Critical Residues in the Catalytic Domain of Human Neuropathy Target EsteraseJournal of Biological Chemistry, 2000
- Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agentsJournal of Applied Toxicology, 1998
- Intermediate myasthenia syndrome following acute organophosphates poisoning — an analysis of 21 casesHuman & Experimental Toxicology, 1998
- Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidaseBiochemical Pharmacology, 1997
- Fatty Acid Sulfonyl Fluorides Inhibit Anandamide Metabolism and Bind to the Cannabinoid ReceptorBiochemical and Biophysical Research Communications, 1997
- Review : Neuropsychopathological changes by organophosphorus compounds — a reviewHuman & Experimental Toxicology, 1995
- Intermediate syndrome in organophosphorus poisoningCritical Care Medicine, 1993
- Acute toxicity of pesticidesToxicology and Applied Pharmacology, 1969
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961